CorMedix
CRMD
34 hedge funds and large institutions have $1.96M invested in CorMedix in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
25% more capital invested
Capital invested by funds: $1.56M → $1.96M (+$396K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.1% less ownership
Funds ownership: 2.12% → 2.02% (-0.1%)
3% less funds holding
Funds holding: 35 → 34 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $19K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$43.5K |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$6.94K |
| 3 |
Franklin Resources
San Mateo,
California
|
+$3.68K |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$3.17K |
| 5 |
Millennium Management
New York
|
+$2.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$48.9K |
| 2 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
-$40K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$14K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$10.8K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$6.43K |
CRMD Hedge Fund Activity: Q2 2018 in Review
34 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2018, worth a combined $1.96M — up 25% from $1.56M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CRMD and 5 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 5 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $43.5K. The largest seller was Citadel Advisors, cutting an estimated $48.9K.
- 34 institutional investors held CorMedix (CRMD) as of Q2 2018, down from 35 in Q1 2018.
- Funds reported $1.96M of CorMedix stock for Q2 2018, up 25% quarter-over-quarter.
- 5 funds opened new CorMedix positions in Q2 2018 and 6 closed out, a net change of -1 holder.
- The largest CorMedix buyer in Q2 2018 was Virtu Financial, an estimated $43.5K added.
- The largest CorMedix seller in Q2 2018 was Citadel Advisors, an estimated $48.9K sold.
Based on aggregated 13F filings for Q2 2018.